Menu

利伐沙班片主治什么?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

What does Rivaroxaban tablets treat? Indications include: ① Use in adult patients undergoing elective hip or knee replacement surgery to prevent venous thrombosis (VTE). ②It is used to treat venous thrombosis (DVT) in adults and reduce the risk of DVT recurrence and pulmonary embolism (PE) after acute DVT. ③For use in adult patients with non-valvular atrial fibrillation who have one or more risk factors (such as congestive heart failure, hypertension, diabetes, stroke or transient ischemic attack history) to reduce the risk of stroke and systemic embolism.

Rivaroxaban is a direct oral factor

Compared with traditional anticoagulant drugs, rivaroxaban has the advantages of high safety, accurate efficacy, high oral bioavailability, few food and drug interactions, and no need for laboratory monitoring and drug dosage adjustment. It has high clinical promotion and use value and provides clinicians with a new choice for individualized medication.

It was officially approved for sale in China in March 2009, and has also been included in the national medical insurance to provide everyone with government discounts to reduce the financial burden. But even after medical insurance, the price of rivaroxaban remains high, prohibiting many families. However, according to what Medical Companion Travel has learned, the most popular one on the market is Germany's Bayer's rivaroxaban, which is priced at only $350 for 20mg*28 tablets. Compared with other versions, this version is more cost-effective and more suitable for long-term use by patients. Since the exchange rate has been in a state of fluctuation for a long time, the price fluctuates with the exchange rate and is not static. For more information about rivaroxaban, please contact Medical Companion Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related hot articles:

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。